Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer

Jenny Y Yoo; Michael T Stang

doi:10.1016/j.soc.2015.08.002

Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer

Surg Oncol Clin N Am. 2016 Jan;25(1):41-59. doi: 10.1016/j.soc.2015.08.002.

Authors

Jenny Y Yoo¹, Michael T Stang²

Affiliations

¹ Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, 3471 Fifth Avenue, Kaufman Building, Suite 101, Pittsburgh, PA 15213, USA.
² Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, 3471 Fifth Avenue, Kaufman Building, Suite 101, Pittsburgh, PA 15213, USA. Electronic address: stangmt@upmc.edu.

PMID: 26610773
DOI: 10.1016/j.soc.2015.08.002

Abstract

Well-differentiated thyroid cancer is increasing in incidence but the disease-specific mortality remains very low. The only effective adjuvant treatment is radioactive iodine ablation. Guidelines regarding the use and dosage of radioactive iodine depend on pathologic features of the primary and metastatic tumor that define risk. Long-term treatment includes thyroid-stimulating hormone suppression and surveillance with serum thyroglobulin and radiologic assessment for nodal recurrence.

Keywords: I(131); Radioactive iodine; TSH suppression; Thyroid cancer.

Publication types

Review

MeSH terms

Adenocarcinoma, Follicular / therapy*
Carcinoma / therapy*
Carcinoma, Papillary
Combined Modality Therapy / methods*
Humans
Postoperative Care / methods*
Thyroid Cancer, Papillary
Thyroid Neoplasms / therapy*